e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Diagnosis of thoracic malignancies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is it useful performing pathology analysis on all samples from bronchoscopically accessible lung tumours?
G. Jifon, D. Butterworth, M. Winson (Crewe, United Kingdom)
Source:
Annual Congress 2007 - Diagnosis of thoracic malignancies
Session:
Diagnosis of thoracic malignancies
Session type:
Thematic Poster Session
Number:
3883
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Jifon, D. Butterworth, M. Winson (Crewe, United Kingdom). Is it useful performing pathology analysis on all samples from bronchoscopically accessible lung tumours?. Eur Respir J 2007; 30: Suppl. 51, 3883
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Challenges in the management of SCLC
Related content which might interest you:
Is bronchoscopic lung biopsy helpful in the management of patients with diffuse lung disease?
Source: Eur Respir J 2007; 29: 1064
Year: 2007
Blind bronchoscopic lung biopsy (BLB) as a primary approach to the evaluation of peripheral lung lesions
Source: Annual Congress 2009 - Trends in bronchoscopy
Year: 2009
Is virtual bronchoscopy (VB) useful in diagnosing of peripheral lung cancer?
Source: Eur Respir J 2007; 30: Suppl. 51, 667s
Year: 2007
Rinse fluid cytology specimens add value to standard bronchoscopic sampling techniques in the diagnosis of lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 361s
Year: 2003
Bronchoscopic findings in lung cancer: diagnostic yield of specimen collection method compared to histological type
Source: Eur Respir J 2005; 26: Suppl. 49, 534s
Year: 2005
The value of obtaining brushing samples in addition to biopsy and washings in the diagnosis of lung cancer
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Bronchoscopic brushing from central lung cancer – Next generation sequencing results are reliable
Source: International Congress 2019 – Diagnosis of lung cancer
Year: 2019
Transbronchial lung biopsy (TLB): still a valid tool to lung disease diagnosis?
Source: Eur Respir J 2006; 28: Suppl. 50, 516s
Year: 2006
Usefulness of various diagnostic techniques during fiberoptic bronchoscopy for endoscopically visible lung cancer: should cytologic examinations be performed routinely?
Source: Eur Respir J 2001; 18: Suppl. 33, 326s
Year: 2001
Lung cancer detection by computer assisted analysis of novel biomarkers in induced sputum samples
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
Is an informative application a suitable tool for patients in a diagnostic lung cancer program?A qualitative study
Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases
Year: 2021
VATS lung biopsy is the method of choice for patients with ambiguous pulmonary pathology to establish a morphologic diagnosis
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011
The clinical value of autofluorescence bronchoscopy for the diagnosis of lung cancer
Source: Eur Respir J 2006; 28: 915-919
Year: 2006
Are surgical approaches for the solitary pulmonary nodule that are evaluated as malignant lung tumors acceptable?
Source: Eur Respir J 2005; 26: Suppl. 49, 172s
Year: 2005
The Choice of lung biopsy method in the presence of limited focal lesions.
Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease
Year: 2019
Updates in using a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples
Source: Breathe, 16 (3) 200067; 10.1183/20734735.0067-2020
Year: 2020
How do cytology samples compare with histology specimens when used for EGFR testing in patients with NSCLC?
Source: Annual Congress 2012 - Progress in endoscopy for lung cancer
Year: 2012
Is transbronchial lung biopsy using cryoprobes useful in the management of diffuse lung disease?
Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions
Year: 2013
Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens
Source: Eur Respir Rev, 26 (144) 170007; 10.1183/16000617.0007-2017
Year: 2017
HER-2/neu expression in bioptic and surgical samples of non small cell lung carcinoma
Source: Eur Respir J 2002; 20: Suppl. 38, 3s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept